Clinical Trial Results:
A Phase II, Randomised, Open-label, Pilot Study to Evaluate the Safety and the Effects on Bone Resorption of AZD0530 in Patients with Prostate Cancer or Breast Cancer with Metastatic Bone Disease
Ensayo piloto, fase II, abierto y aleatorizado para evaluar la seguridad y los efectos de AZD0530 sobre la resorción ósea en pacientes con cáncer de próstata o de mama con metástasis óseas
Summary
|
|
EudraCT number |
2007-005999-13 |
Trial protocol |
ES GB SE PT DK |
Global completion date |
20 Aug 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Oct 2016
|
First version publication date |
08 Oct 2016
|
Other versions |
|
Summary report(s) |
CSR_D8180C00034 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.